Sorry, you need to enable JavaScript to visit this website.

Authors' reply to: Inhibition of immune responses by Dasatinib may account for its different effects on neuroblastoma between in vitro and in vivo

TitleAuthors' reply to: Inhibition of immune responses by Dasatinib may account for its different effects on neuroblastoma between in vitro and in vivo
Publication TypeArticolo su Rivista peer-reviewed
Year of Publication2010
AuthorsVitali, Roberta, and Raschellà Giuseppe
JournalInternational Journal of Cancer
Volume127
Pagination1250
ISSN00207136
KeywordsAdaptive Immunity, Apoptosis, cancer cell culture, cancer transplantation, CD4+ T lymphocyte, cellular immunity, dasatinib, drug effect, drug inhibition, human, immune response, in vitro study, in vivo study, letter, natural killer cell, Neuroblastoma, nonhuman, priority journal
Notes

cited By 0

URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-77957288574&doi=10.1002%2fijc.25128&partnerID=40&md5=10911105df82adceb34be8aba6ae5d22
DOI10.1002/ijc.25128
Citation KeyVitali20101250